Head-to-head Comparison of Empagliflozin and Dapagliflozin

NCT03748810 · clinicaltrials.gov ↗

COMPLETED

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Type2 Diabetes

Interventions

DRUG: Empagliflozin
DRUG: Dapagliflozin

Sponsor

Chungbuk National University Hospital